Literature DB >> 2659598

Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.

Y S Yuh1, E B Thompson.   

Abstract

Glucocorticoids induce growth inhibition and eventually cause cell lysis in certain sensitive leukemic cells. To investigate how glucocorticoids interact with cell growth pathways, we studied the expression of 14 growth-related genes in dexamethasone-treated CEM-C7A cells, a steroid-sensitive clone of the CCRF-CEM cell line, and in several closely related clones. The 14 genes studied were chosen to represent four different levels of mitogenic signal transduction. Detectable mRNA levels were found for 8 of the 14 genes, but among these only c-myc expression was obviously suppressed by dexamethasone. The c-myc mRNA levels declined abruptly during the first 12 h after addition of 1 microM dexamethasone, and maximal suppression occurred by 18 h. This change was not seen in the C7A controls, in the glucocorticoid-resistant, receptor-deficient clone ICR-27, or in the glucocorticoid-resistant, receptor-positive clone C1. H.10, a hybrid clone between C1 and ICR-27, showed restoration of the sensitive phenotype, and in H.10 cells the c-myc mRNA was also suppressed by dexamethasone. Our results suggest that: 1) functional glucocorticoid receptor is required for inducing c-myc suppression. 2) In dexamethasone-resistant cells with functional receptors c-myc is not suppressed. 3) The growth arrest induced by glucocorticoids correlates with, and may be regulated via, suppression of c-myc expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659598

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Apoptosis induced by anticancer drugs.

Authors:  J A Hickman
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Thyroid hormone regulation of Na,K-ATPase subunit-mRNA expression in neonatal rat myocardium.

Authors:  J Melikian; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

Review 3.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

4.  Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.

Authors:  M Maroder; S Martinotti; A Vacca; I Screpanti; E Petrangeli; L Frati; A Gulino
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

Review 5.  Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways.

Authors:  M S Webb; A L Miller; T L Howard; B H Johnson; S Chumakov; Y Fofanov; T Nguyen-Vu; C Y Lin; E B Thompson
Journal:  Mol Cell Endocrinol       Date:  2018-03-26       Impact factor: 4.102

6.  Association of nbl gene expression and glucocorticoid-induced apoptosis in mouse thymus in vivo.

Authors:  H Naora; T Nishida; Y Shindo; M Adachi; H Naora
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

7.  Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius.

Authors:  P E Neiman; C Blish; C Heydt; G Loring; S J Thomas
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

8.  The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.

Authors:  D A Albert
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis.

Authors:  Rheem D Medh; M Scott Webb; Aaron L Miller; Betty H Johnson; Yuriy Fofanov; Tongbin Li; Thomas G Wood; Bruce A Luxon; E Brad Thompson
Journal:  Genomics       Date:  2003-06       Impact factor: 5.736

Review 10.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.